Effectiveness of EGFR-TKIs versus Chemotherapy as First-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis

Effectiveness of EGFR-TKIs versus Chemotherapy as First-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis

Background and objective Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) has been used for the first-line treatment of non-small cell lung cancer (NSCLC) and has shown good clinical effects. However, some patients fail to benefit from this treatment. The aim of this study is to...

Full description

Bibliographic Details
Main Authors: Feifei CAO, Linlin ZHANG, Shuang WANG, Diansheng ZHONG, Yan WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-03-01
Series:Chinese Journal of Lung Cancer
Subjects:
EGFR-TKIs
Lung neoplasms
Chemotherapy
First-line treatment
Meta-analysis
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.03.04

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2015.03.04

Similar Items